Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
holding | OKMN | Common Stock | 3M | Nov 8, 2022 | Direct | ||||||
holding | OKMN | Common Stock | 1.25M | Nov 8, 2022 | By Roy Mansano MD APMC |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | OKMN | 10% Convertible Loan | Other | $1.69K | $225K | Nov 8, 2022 | Common Stock | 56.3K | $0.03 | By Roy Mansano MD APMC | F1, F2 | |||
transaction | OKMN | Warrants | Other | $0 | +18.8K | +0.76% | $0.00 | 2.5M | Nov 8, 2022 | Common Stock | 18.8K | By Roy Mansano MD APMC | F3 | |
transaction | OKMN | 10% Convertible Loan | Other | -$3.5K | $221K | Nov 8, 2022 | Common Stock | 117K | $0.03 | By Roy Mansano MD APMC | F4, F5 | |||
transaction | OKMN | Warrants | Other | $0 | -38.9K | -1.56% | $0.00 | 2.46M | Nov 8, 2022 | Common Stock | 38.9K | By Roy Mansano MD APMC | F6 | |
transaction | OKMN | 10% Convertible Loan | Other | $1.66K | $223K | Dec 8, 2022 | Common Stock | 55.3K | $0.03 | By Roy Mansano MD APMC | F1, F7 | |||
transaction | OKMN | Warrants | Other | $0 | +18.4K | +0.75% | $0.00 | 2.48M | Dec 8, 2022 | Common Stock | 18.4K | By Roy Mansano MD APMC | F3 | |
transaction | OKMN | 10% Convertible Loan | Other | -$3.5K | $219K | Dec 8, 2022 | Common Stock | 117K | $0.03 | By Roy Mansano MD APMC | F4, F8 | |||
transaction | OKMN | Warrants | Other | $0 | -38.9K | -1.57% | $0.00 | 2.44M | Dec 8, 2022 | Common Stock | 38.9K | By Roy Mansano MD APMC | F6 | |
transaction | OKMN | 10% Convertible Loan | Other | -$45.5K | 174K | Jan 3, 2023 | Common Stock | 1.52M | $0.03 | By Roy Mansano MD APMC | F9, F10 | |||
transaction | OKMN | Warrants | Other | $0 | -506K | -20.74% | $0.00 | 1.93M | Jan 3, 2023 | Common Stock | 506K | By Roy Mansano MD APMC | F9 |
Roy Mansano is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.
Id | Content |
---|---|
F1 | Represents interest accrued on the 10% Convertible Loan (the "Loan") on this date. The outstanding principal and accrued interest on the Loan (the "Loan Amount") is convertible at any time into shares of Common Stock at a conversion price of $0.03 per share. For every three shares of Common Stock received upon conversion of the Loan Amount, the holder will also receive one Warrant to buy an additional share of Common Stock at an exercise price of $0.03 per share. The Warrants underlying the Loan Amount are also reported on this form. |
F2 | The total number of shares underlying the Loan Amount after this transaction (not including shares underlying Warrants) is 7,492,001. |
F3 | These Warrants are not currently outstanding but may be issued upon conversion of the interest that was accrued on the Loan on this date. The Warrants will be exercisable immediately if and when issued and will have an exercise price of $0.03 per share and a three-year term. |
F4 | Represents a Loan payment on this date, which reduced the Loan Amount by the amount of the payment. |
F5 | The total number of shares underlying the Loan Amount after this transaction (not including shares underlying Warrants) is 7,375,334. |
F6 | These Warrants were subject to issuance upon conversion of the Loan Amount that was paid on this date. The Warrants would have been exercisable immediately if and when issued and would have had an exercise price of $0.03 per share and a three-year term. |
F7 | The total number of shares underlying the Loan Amount after this transaction (not including shares underlying Warrants) is 7,430,649. |
F8 | The total number of shares underlying the Loan Amount after this transaction (not including shares underlying Warrants) is 7,313,983. |
F9 | On January 3, 2023, the terms of the Loan were amended to provide that at no time shall the reporting person be permitted to convert any portion of the Loan Amount if such conversion would result in his being the beneficial owner of more than 9.99% of the issuer's class of Common Stock. The amendment had the effect of reducing the reporting person's beneficial ownership on this date to below 9.99% as indicated. |
F10 | The total number of shares underlying the Loan Amount after this transaction (not including shares underlying Warrants) is 5,796,882. |